Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1995
12/19/1995US5476784 Medical diagnosis
12/19/1995US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease
12/19/1995US5476658 Vaccine against hepatitis a comprising simian HAV isolate AGM-27
12/19/1995US5476657 Pasteurella haemolytica leukotoxin compositions and uses thereof
12/19/1995CA2011654C Recombinant poxvirus host range selection system
12/19/1995CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas
12/18/1995CA2149197A1 Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
12/15/1995CA2150994A1 P53as protein and antibody therefor
12/14/1995WO1995033997A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995WO1995033835A1 Nucleic acid immunization using a virus-based infection/transfection system
12/14/1995WO1995033828A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
12/14/1995WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995WO1995033767A1 Helicobacter pylori nickel binding protein
12/14/1995WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033482A1 Treatment and prevention of helicobacter infection
12/14/1995WO1995033481A1 Diphtheria toxin vaccines bearing a mutated r domain
12/14/1995WO1995033479A1 Cytotoxic enhancement of tnf with copper
12/14/1995CA2192468A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995CA2192370A1 Monoclonal antibody active against cd44v6
12/14/1995CA2192312A1 Helicobacter pylori nickel binding protein
12/14/1995CA2191891A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants
12/14/1995CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995CA2191362A1 Nucleic acid immunization using a virus-based infection/transfection system
12/14/1995CA2191239A1 Diphtheria toxin vaccines bearing a mutated r domain
12/13/1995EP0686694A1 Use of azoles as virucidal agents in solutions of biologically active proteins
12/13/1995EP0686265A1 Methods of inducing immunity to lyme disease and a colorimetric assay for borreliacidal activity of antisera
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/13/1995EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995EP0686042A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
12/13/1995EP0686039A1 Method of enhancing immune response to oral vaccines
12/13/1995EP0686030A1 Immunological response potentiation process
12/13/1995CN1113158A Infectious bursal disease vaccine
12/12/1995US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells
12/12/1995US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion
12/12/1995US5475091 Monoclonal antibodies produced by a hybridoma cell; antiinflammatory agents
12/12/1995US5475087 Polypeptides
12/12/1995US5475086 Proline-glutamic acid-valine-lysine-glutamic acid-lysine containing oligopeptides or polypeptides; useful or diagnosis or therapy of autoimmune diseases such as insulin-dependent diabetes mellitus
12/12/1995US5474914 Method of producing secreted CMV glycoprotein H
12/12/1995US5474905 Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
12/12/1995US5474773 Human rotaviruses, vaccines and method
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995CA2005365C Medication for the treatment or prevention of hiv virus infection through passive immunization and processes for its preparation
12/12/1995CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them
12/09/1995CA2125426A1 Rhodococcus equi gene sequence
12/07/1995WO1995033059A2 Receptor for oncostatin m
12/07/1995WO1995033053A1 Hepatitis c virus asialoglycoproteins
12/07/1995WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors
12/07/1995WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS
12/07/1995WO1995033048A2 P2x receptors (purinoceptor family)
12/07/1995WO1995032988A1 Novel parasite protease genes and proteins
12/07/1995WO1995032982A1 Dna encoding gls1
12/07/1995WO1995032735A2 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease
12/07/1995WO1995032734A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness
12/07/1995WO1995032733A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
12/07/1995WO1995032731A2 Immunogenic pharmaceuticals
12/07/1995WO1995032729A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
12/07/1995WO1995032724A1 Glial mitogenic factors, their preparation and use
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents
12/07/1995WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/07/1995WO1995030435A3 Compositions and treatment for multiple sclerosis
12/07/1995WO1995026980A3 Haptenated peptides and uses thereof
12/07/1995WO1995024485A3 Coordinate in vivo gene expression
12/07/1995DE4419294A1 Legionella pneumophila DNA coding for major outer membrane protein
12/07/1995CA2191085A1 Glial mitogenic factors, their preparation and use
12/07/1995CA2191071A1 Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof used as growth factor inhibitors
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2191067A1 Dna encoding gls1
12/07/1995CA2190265A1 Hepatitis c virus asialoglycoproteins
12/07/1995CA2189741A1 Novel parasite protease genes and proteins
12/07/1995CA2188812A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness
12/07/1995CA2167936A1 Tbp2 fragments of the transferrine receptor of neisseria meningitidis
12/06/1995EP0685236A1 Prevention and treatment of retroviral disease
12/06/1995EP0684996A1 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same
12/06/1995EP0684994A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies
12/06/1995EP0684990A1 Novel receptor-type phosphotyrosine phosphatase-gamma
12/06/1995EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta
12/06/1995EP0684957A1 $i(STREPTOCOCCUS SUIS) ADHESIN PROTEIN AND METHOD FOR PRODUCING IT
12/06/1995EP0684955A1 Nuclear matrix proteins
12/06/1995EP0684838A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
12/06/1995EP0684831A1 Allogeneic vaccine and method to synthesize same
12/06/1995EP0684828A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
12/06/1995EP0610250B1 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
12/06/1995EP0490998B1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
12/05/1995US5473051 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs
12/05/1995US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/05/1995US5472849 Method for detecting inflammation
12/05/1995US5472696 Antigen of group B streptococci
12/05/1995US5472693 Monoclonal antibodies
12/05/1995CA1337688C Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
11/1995
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032300A1 Selective biological destruction of tumor cells
11/30/1995WO1995032296A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
1 ... 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 ... 1823